Bioinformatics analysis of expression and function of EXD3 gene in gastric cancer.
10.12122/j.issn.1673-4254.2019.02.14
- Author:
Dengzhong SUN
1
;
Mulin LIU
1
;
Fuxin HUANG
2
;
Fuxin HUANG
2
Author Information
1. Department of Gastrointestinal Surgery, Bengbu Medical College, Bengbu 233003, China.
2. First Affiliated Hospital, Department of Biological Sciences, Bengbu Medical College, Bengbu 233003, China.
- Publication Type:Journal Article
- Keywords:
EXD3;
bioinformatics analysis;
gastric cancer;
prognosis
- MeSH:
Computational Biology;
Databases, Genetic;
Exonucleases;
genetics;
Gastric Mucosa;
chemistry;
enzymology;
Gene Expression Profiling;
Gene Expression Regulation, Neoplastic;
Humans;
Neoplasm Proteins;
genetics;
Prognosis;
Stomach Neoplasms;
enzymology;
genetics;
mortality
- From:
Journal of Southern Medical University
2019;39(2):215-221
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the differentially expressed genes between gastric cancer and normal gastric mucosa by bioinformatics analysis, identify the important gene participating in the occurrence and progression of gastric cancer, and predict the functions of these genes.
METHODS:The gene expression microarray data GSE100935 (including 18 gastric cancer samples and normal gastric mucosal tissues) downloaded from the GEO expression profile database were analyzed using Morpheus to obtain the differentially expressed genes in gastric cancer, and a cluster analysis heat map was constructed. The online database UALCAN was used to obtain the expression levels of these differentially expressed genes in gastric cancer and normal gastric mucosa. The prognostic value of the differentially expressed genes in gastric cancer was evaluated with Kaplan-Meier survival analysis. GO functional enrichment analysis was performed using Fun-Rich software, and the STRING database was exploited to establish a PPI network for the differentially expressed genes.
RESULTS:A total of 45119 differentially expressed genes were identified from GSE100935 microarray data. Analysis with UALCAN showed an obvious high expression of EXD3 gene in gastric cancer, and survival analysis suggested that a high expression level of EXD3 was associated with a poorer prognosis of the patients with gastric cancer. GO functional enrichment analysis found that the differentially expressed genes in gastric cancer were involved mainly in the regulation of nucleotide metabolism and the activity of transcription factors in the cancer cells.
CONCLUSIONS:EXD3 may be a potential oncogene in gastric cancer possibly in relation to DNA damage repair. The up-regulation of EXD3 plays an important role in the development and prognosis of gastric cancer, and may serve as an important indicator for prognostic evaluation of the patients.
